electroCore, Inc. financial data

Symbol
ECOR on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
200 Forge Way, Suite 205, Rockaway, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
ElectroCore, LLC (to 6/20/2018)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 195 % -17%
Quick Ratio 29.6 % -11.2%
Debt-to-equity 123 % +91.1%
Return On Equity -94.1 % -27.9%
Return On Assets -69.2 % +35%
Operating Margin -55.9 % +64.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.55M shares +9.2%
Common Stock, Shares, Outstanding 6.51M shares +8.47%
Entity Public Float 22.4M USD -32.5%
Common Stock, Value, Issued 6K USD +20%
Weighted Average Number of Shares Outstanding, Basic 8.09M shares +36.1%
Weighted Average Number of Shares Outstanding, Diluted 8.09M shares +36.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 23.3M USD +74.1%
Research and Development Expense 2.66M USD -54.4%
Operating Income (Loss) -13M USD +38.5%
Nonoperating Income (Expense) 262K USD -40.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.8M USD +38.5%
Income Tax Expense (Benefit) -122K USD +42.2%
Net Income (Loss) Attributable to Parent -12.7M USD +38.4%
Earnings Per Share, Basic -1.69 USD/shares +58.2%
Earnings Per Share, Diluted -1.69 USD/shares +58.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.93M USD -63.4%
Marketable Securities, Current 8.02M USD
Cash, Cash Equivalents, and Short-term Investments 13.2M USD
Accounts Receivable, after Allowance for Credit Loss, Current 552K USD -6.28%
Inventory, Net 1.96M USD -21.6%
Assets, Current 16.8M USD -5.94%
Property, Plant and Equipment, Net 170K USD -4.49%
Operating Lease, Right-of-Use Asset 3.73M USD +620%
Other Assets, Noncurrent 364K USD -52.1%
Assets 21M USD +4.66%
Accounts Payable, Current 1.24M USD -59.1%
Accrued Liabilities, Current 6.31M USD +17%
Liabilities, Current 7.91M USD -7.01%
Operating Lease, Liability, Noncurrent 3.68M USD +557%
Liabilities 11.6M USD +27.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 177K USD
Retained Earnings (Accumulated Deficit) -174M USD -7.87%
Stockholders' Equity Attributable to Parent 9.46M USD -14.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.8M USD -62.7%
Liabilities and Equity 21M USD +4.66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.56M USD +56.3%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 6.51M shares +8.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.48M USD +57.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.18M USD -62.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD +150%
Deferred Tax Assets, Valuation Allowance 40.6M USD +9.5%
Deferred Tax Assets, Gross 40.8M USD +9.36%
Operating Lease, Liability 4.04M USD +527%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.4M USD +41.7%
Lessee, Operating Lease, Liability, to be Paid 10.6M USD +1059%
Operating Lease, Liability, Current 363K USD +327%
Lessee, Operating Lease, Liability, to be Paid, Year Two 516K USD +202%
Lessee, Operating Lease, Liability, to be Paid, Year One 369K USD +120%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.55M USD +2336%
Lessee, Operating Lease, Liability, to be Paid, Year Three 603K USD +275%
Deferred Tax Assets, Operating Loss Carryforwards 33.6M USD +12.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 627K USD +299%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 206K USD +68.9%
Deferred Tax Assets, Net of Valuation Allowance 285K USD -6.86%
Share-based Payment Arrangement, Expense 1.76M USD -6.84%
Interest Expense 2.25K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%